1. Pharmacology of a new calcium antagonist compound isobutyl methyl 1,4dihydro-2, 6-dimethyl-4 (2-nitrophenyl) 3,5-pyridinedicarboxylate (nisoldipine, Bay 5552);Kazda, S.; Garthoff, B.; Meyer, H.;Arzneim-Forsch Drug Res,1980
2. Effect of nisoldipine upon the general and coronary hemodynamics of the anesthetized dog;Maxwell, G.M.; Crompton, S.; Renics, V.;J Cardiovasc Pharmacol,1982
3. Blood flow in normal and acutely ischaemic myocardium after verapamil, diltiazem and nisoldipine (Bay 5552), a new dihydropyridine calcium antagonist;Warltier, D.C.; Meils, C.M.; Garrett, J.G.; Brooks, H.L.;J Pharmacol Exp Ther
4. Double blind double dummy cross-over study of the efficacy and safety of nisoldipine (BAYk 5552) versus nifedipine;Rosendorff, C.; Goodman, C.;Clin Therapeut Res
5. Nifedipine and nisoldipine in hypertensive diabetics;Clarke, C.W.F.; Kubik, M.M.;J Hum Hypertens,1991